These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11383874)

  • 21. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary?
    Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective radionuclide localisation in primary liver tumours (pilot study).
    Novell JR; Green AJ; Hilson AJ; Dusheiko G; Dick R; Hobbs KE
    HPB Surg; 1994; 7(3):185-99; discussion 200. PubMed ID: 8155585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
    Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
    Raoul JL; Boucher E; Roland V; Garin E
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of cisplatin and intra-arterial injection of 131I-lipiodol in treatment of hepatocellular carcinoma: results of phase II trial.
    Raoul JL; Boucher E; Olivie D; Guillygomarc'h A; Boudjema K; Garin E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):745-50. PubMed ID: 16289908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of [131I]lipiodol as a hepatoma therapeutic agent.
    Lo JG; Wang AY; Wei YY; Lui WY; Chi CW; Chan WK
    Int J Rad Appl Instrum A; 1992 Dec; 43(12):1431-5. PubMed ID: 1334953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol).
    Kobayashi H; Nakajo M; Yano T; Shimabukuro K; Shinohara S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1176-8. PubMed ID: 3005962
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow.
    de Baere T; Taourel P; Tubiana JM; Kuoch V; Ducreux M; Lumbroso J; Roche AJ
    Radiology; 1999 Sep; 212(3):665-8. PubMed ID: 10478229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
    Launois B; Maddern G
    Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
    [No Abstract]   [Full Text] [Related]  

  • 30. Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma.
    Maini CL; Scelsa MG; Fiumara C; Tofani A; Sciuto R; Tipaldi L; D'Annibale M; Santoro E
    Clin Nucl Med; 1996 Mar; 21(3):221-6. PubMed ID: 8846568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of unresectable hepatocellular carcinoma with transarterial radioembolization: iodine-131-lipiodol.
    Lau WY; Lai EC
    ANZ J Surg; 2008 May; 78(5):331-2. PubMed ID: 18380721
    [No Abstract]   [Full Text] [Related]  

  • 32. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer.
    Nakajo M; Kobayashi H; Shimabukuro K; Shirono K; Sakata H; Taguchi M; Uchiyama N; Sonoda T; Shinohara S
    J Nucl Med; 1988 Jun; 29(6):1066-77. PubMed ID: 2836573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
    Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings.
    Yoo HS; Park CH; Suh JH; Lee JT; Kim DI; Kim BS; Madsen MT
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S54-8. PubMed ID: 2538267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
    Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
    Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interventional nuclear medicine in hepatocellular carcinoma and other tumours.
    Buscombe JR
    Nucl Med Commun; 2002 Sep; 23(9):837-41. PubMed ID: 12195086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
    Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL
    J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution.
    Yumoto Y; Jinno K; Inatsuki S; Moriwaki S; Hanafusa T; Yumoto E; Shiota T; Higashi T; Koide N; Hada H
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S128-36. PubMed ID: 1281043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
    Boucher E; Garin E; Guylligomarc'h A; Olivié D; Boudjema K; Raoul JL
    Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of hepatocellular carcinoma with 131I-lipiodol: patient dosimetry.
    Risse JH; Pauleit D; Palmedo H; Bender H; Bucerius J; Ezziddin S; Klein V; Grünwald F; Biersack HJ; Reichmann K
    Nuklearmedizin; 2007; 46(5):192-7. PubMed ID: 17938753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.